| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 14.172 | 102.113 | 159.305 | 350.342 |
| Total Income - EUR | - | - | - | - | - | - | 14.324 | 102.278 | 159.468 | 350.374 |
| Total Expenses - EUR | - | - | - | - | - | - | 38.466 | 137.237 | 178.568 | 369.919 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -24.142 | -34.960 | -19.100 | -19.545 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -24.142 | -34.960 | -19.100 | -19.545 |
| Employees | - | - | - | - | - | - | 4 | 3 | 3 | 4 |
Check the financial reports for the company - Paradisul Bio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 6.960 | 6.854 | 7.763 | 26.790 |
| Current Assets | - | - | - | - | - | - | 33.266 | 41.668 | 39.966 | 50.636 |
| Inventories | - | - | - | - | - | - | 26.743 | 28.395 | 26.872 | 30.638 |
| Receivables | - | - | - | - | - | - | 3.494 | 3.734 | 2.643 | 4.644 |
| Cash | - | - | - | - | - | - | 3.029 | 9.538 | 10.452 | 15.354 |
| Shareholders Funds | - | - | - | - | - | - | -13.792 | -48.794 | -67.746 | -86.913 |
| Social Capital | - | - | - | - | - | - | 10.350 | 10.382 | 10.351 | 10.293 |
| Debts | - | - | - | - | - | - | 54.018 | 97.316 | 115.475 | 164.339 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4727 - 4727" | |||||||||
| CAEN Financial Year |
4729
|
|||||||||
Comments - Paradisul Bio S.r.l.